Tariquidar
Tariquidar is a third-generation P-glycoprotein inhibitor, which is used in the field of pharmacology to enhance the effectiveness of certain drugs. It is a non-competitive inhibitor that has been shown to restore drug sensitivity in multidrug resistance.
History[edit]
Tariquidar was developed by Xenova Group, a British biotechnology company, in the late 1990s. The development of Tariquidar was part of a larger effort to combat multidrug resistance in cancer treatment.
Mechanism of Action[edit]
Tariquidar works by inhibiting the action of P-glycoprotein, a protein that pumps foreign substances out of cells. This protein is often overexpressed in cancer cells, leading to multidrug resistance. By inhibiting P-glycoprotein, Tariquidar allows more of the drug to remain in the cancer cells, increasing its effectiveness.
Clinical Trials[edit]
Several clinical trials have been conducted to test the effectiveness of Tariquidar. These trials have shown that Tariquidar can enhance the effectiveness of certain chemotherapy drugs in treating various types of cancer.
Side Effects[edit]
Like all drugs, Tariquidar has potential side effects. These can include nausea, vomiting, and diarrhea. More serious side effects can include heart problems and low blood cell counts.
Future Research[edit]
Future research on Tariquidar is focused on further understanding its mechanism of action and potential uses in cancer treatment. There is also interest in exploring its potential use in treating other diseases where multidrug resistance is a problem.
 | This oncology article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
